Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline SVV Q1 2026 Earnings Narrow EPS Miss Amid Positive Market Response CRGO Q4 2025 Earnings Narrower Loss Slightly Ahead of Expectations ELMD Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction GAU Q1 2026 Earnings Gold Producer Reports EPS Below Estimates Stock Gains Slightly YELP Q1 2026 Earnings EPS Beats Estimates by 117 as Stock Rises